This lack of association between PSA kinetics and biochemical relapse has been reported in numerous studies that have investigated ARPI-treated populations, and the insufficient sensitivity of PSA alone to detect early resistance in hormone-sensitive disease [28]. This evidence concerns the gene KLK3 and glycogen storage disease VI.